Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Importin subunit alpha-1 (KPNA2) is a critical adapter protein within the karyopherin alpha family, primarily responsible for the nucleocytoplasmic transport of proteins containing a nuclear localization signal (NLS) (UniProt P52294). It functions by binding to cargo proteins in the cytoplasm and subsequently associating with importin beta-1 to facilitate passage through the nuclear pore complex (NCBI Gene 3838). KPNA2 is involved in the nuclear import of several key regulatory proteins, including transcription factors like E2F1, NF-kappaB, and p53, as well as proteins involved in DNA repair and cell cycle progression (PMID: 33456565). In oncology, KPNA2 is frequently overexpressed across a wide range of malignancies, including breast, lung, and liver cancers, where its high expression levels correlate with increased tumor aggressiveness, poor patient prognosis, and resistance to therapy (PMID: 28848465). This overexpression facilitates the aberrant nuclear accumulation of oncogenic factors, thereby driving uncontrolled cell proliferation and survival. Consequently, KPNA2 has emerged as a significant therapeutic target, with research focusing on small molecule inhibitors, such as ivermectin, that can disrupt its transport activity and induce apoptosis in cancer cells (PMID: 32251768).
Inhibition of the nuclear import of cargo proteins by blocking the interaction between KPNA2 and nuclear localization signals (NLS) or the importin beta subunit.
2 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Importin subunit alpha-1 (KPNA2) (KPNA2).